Newsbenzinga
Medtronic's Cardiovascular Boom Offsets Margin Pressure
· Published
Article summary
Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.
An excerpt from the original article.
Comments —
Loading comments…